First Wave BioPharma, Inc.
777 Yamato Road, Suite 502
Boca Raton, Florida 33431
(561) 589-7020
| Dear Fellow Stockholder, | | | |
On behalf of the Board of Directors and management of First Wave BioPharma, Inc. (“we”, “us” and(the “Company,” “we,” “us,” or “our”), a Delaware corporation, you are invited to attend our 2022 AnnualSpecial Meeting of Stockholders including any adjournment or postponement thereof (the “Annual“Special Meeting”) to be held on August 25, 2022January 9, 2023 at 9:00 A.M. Eastern Time virtually via the Internet at www.virtualshareholdermeeting.com/FWBI2022.FWBI2023SM.
Details of the business to be conducted at the AnnualSpecial Meeting are described in this proxy statement. We have also made available a copy of our Annual Report on Form 10-K for the year ended December 31, 2021 (as amended on Form 10-K/A filed with the Securities Exchange Commission on May 10, 2022) (the “Annual Report”) with this proxy statement. We encourage you to read our Annual Report. It includes our audited financial statements and provides information about our business and services.
Your vote is important. Regardless of whether you plan to attend the AnnualSpecial Meeting virtually, please read the accompanying proxy statement and then submit your proxy to vote by Internet, telephone or mail as promptly as possible. Returning your proxy will help us assure that a quorum will be present at the AnnualSpecial Meeting and avoid the additional expense of duplicate proxy solicitations. Any stockholder attending the virtual AnnualSpecial Meeting may vote during the virtual meeting, even if he or she has previously voted. Please refer to your proxy card for voting instructions. Submitting your proxy promptly may save us additional expense in soliciting proxies and will ensure that your shares are represented at the AnnualSpecial Meeting.
Our Board of Directors has unanimously approved the proposals set forth in the proxy statement and recommends that you vote in favor of each such proposal.
Sincerely, /s/ James Sapirstein JAMES SAPIRSTEIN President, Chief Executive Officer and Chairman of the Board of Directors | |||
If you have any questions or require any assistance in voting your shares, please call:
Alliance Advisors LLC
200 Broadacres Drive, 3rd3rd Floor, Bloomfield, NJ 07003
866-407-1875